Measurable Residual Disease (MRD) Testing for Acute Leukemia in EBMT Transplant Centers: A Survey on Behalf of The ALWP of the EBMT
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Nagler, A
- Labopin, M
- Polge, E
- Esteve, J
- Bazarbachi, A
- Brissot, E
- Bug, G
- Ciceri, F
- Giebel, S
- Gilleece, M
- Gorin, NC
- Lanza, F
- Peric, Z
- Ruggeri, A
- Savani, B
- Schmid, C
- Shouval, R
- Spyridonidis, A
- Versluis, J
- Baron, F
- Mohty, M
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Cita
Nagler,A,Labopin,M,Polge,E,Esteve,J,Bazarbachi,A,Brissot,E,Bug,G et al. Measurable Residual Disease (MRD) Testing for Acute Leukemia in EBMT Transplant Centers: A Survey on Behalf of The ALWP of the EBMT. CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND:SPRINGERNATURE. 2020 p.p. 545-546.
Portal de investigación